AGIO
NASD Agios Pharmaceuticals, Inc.$31.32 ↓ -0.47 (-1.48%) Trading Down from the previous close of $31.79
- YTD change
- +15.06%
- vs 20-day SMA
- -5.16%
- vs 200-day SMA
- +0.69%
Price ranges
Price & Performance
-1.98 (-5.86%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 68.6% away from all-time highs of $99.82
- AGIO is up 15% since the beginning of the year
- AGIO is down 26% over the past 12 months
- AGIO is down 10% over the past 1 month
- 13% of all AGIO investors are betting against AGIO
AGIO reads not so good: price sits above one of the two key moving averages, the 12-month move is -25.4%.
- Previous minute
- -$0.58
- Last hour
- -$0.68
- Last 5 days
- -5.80%
- vs 8-day SMA
- -3.26%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Agios Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in a research engine, multiple novels, and investigational therapies in preclinical development. It focuses on cellular metabolism and classical hematology. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.